Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,232 | -1,230 | 1,570 | 3,858 | 3,220 |
| Cost of Goods | 688 | -1,932 | 1,128 | 3,447 | 3,458 |
| Gross Profit | 544 | 702 | 442 | 411 | -238 |
| Operating Expenses | 5,099 | 1,380 | 4,561 | 4,641 | 4,843 |
| Operating Income | -3,867 | -1,610 | -3,991 | -3,783 | -4,623 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | -5,336 | 1,490 | 1,704 | -14 | 14 |
| Pre-tax Income | -9,203 | -120 | -2,287 | -3,797 | -4,610 |
| Income Tax | N/A | 13 | 1 | 0 | N/A |
| Net Income Continuous | -9,203 | -133 | -2,288 | -3,797 | -4,610 |
| Net Income Discontinuous | -181 | -4,195 | -589 | N/A | N/A |
| Minority Interests | N/A | -84 | -10 | -20 | -122 |
| Net Income | $-9,384 | $-4,244 | $-2,867 | $-3,777 | $-4,488 |
| EPS Basic Total Ops | -10.86 | -6.08 | -4.67 | -6.81 | -8.09 |
| EPS Basic Continuous Ops | -10.65 | 1.19 | -3.71 | -6.84 | -8.31 |
| EPS Basic Discontinuous Ops | -0.21 | -7.02 | -0.96 | N/A | N/A |
| EPS Diluted Total Ops | -10.86 | -6.08 | -4.67 | -6.81 | -8.09 |
| EPS Diluted Continuous Ops | -10.65 | 1.19 | -3.71 | -6.84 | -8.31 |
| EPS Diluted Discontinuous Ops | -0.21 | -7.02 | -0.96 | N/A | N/A |
| EBITDA(a) | $-3,616 | $-994 | $-3,635 | $-3,316 | $-4,295 |